The Apprentice Doctor

major adverse cardiovascular events

  1. menna omar
    Thread

    Oral Semaglutide: A Game-Changer for Cardiovascular Risk in Type 2 Diabetes

    Oral Semaglutide Reduces Cardiovascular Risk in Patients with Type 2 Diabetes and Comorbidities In a groundbreaking new study presented at the...
    Thread by: menna omar, Mar 31, 2025, 0 replies, in forum: Cardiology
Showing results 1 to 1 of 1
<